BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 6178787)

  • 1. Chemiluminescence response of human natural killer cells. I. The relationship between target cell binding, chemiluminescence, and cytolysis.
    Helfand SL; Werkmeister J; Roder JC
    J Exp Med; 1982 Aug; 156(2):492-505. PubMed ID: 6178787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
    Uchida A; Klein E
    Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemiluminescence response of human natural killer cells. II. Association of a decreased response with low natural killer activity.
    Werkmeister J; Helfand S; Roder J; Pross H
    Eur J Immunol; 1983 Jun; 13(6):514-20. PubMed ID: 6574914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility.
    Uchida A; Vánky F; Klein E
    J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of responses measured by natural cytotoxicity and chemiluminescence.
    Ernst M; Lange A; Flad HD; Havel A; Ennen J; Ulmer AJ
    Eur J Immunol; 1984 Jul; 14(7):634-9. PubMed ID: 6430710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of K562 cells with sodium butyrate. Association of impaired NK susceptibility with sialic acid and analysis of other parameters.
    Werkmeister JA; Pross HF; Roder JC
    Int J Cancer; 1983 Jul; 32(1):71-8. PubMed ID: 6862694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to natural killer cell-mediated cytolysis by a pleiotropic drug-resistant human erythroleukemia (K562-R) cell line.
    Yanovich S; Hall RE; Weinert C
    Cancer Res; 1986 Sep; 46(9):4511-5. PubMed ID: 2425955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The isolation of natural killer (NK)-resistant variants of the K562 cell line by mutagenesis and selection with antibodies which inhibit NK cell-mediated lysis.
    Werkmeister JA; Triglia T; Burns GF
    Cell Immunol; 1985 Apr; 92(1):123-33. PubMed ID: 3865715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
    Frey JR; Kamber M; Peck R
    Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of a dynamic role of the target cell membrane during the early stages of the natural killer cell lethal hit.
    Deem RL; Targan SR
    J Immunol; 1984 Jul; 133(1):72-7. PubMed ID: 6427347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytolysis of mammary tumor targets by resting, interleukin-2 stimulated and in vitro cultured peripheral blood lymphocytes from breast cancer patients.
    Brenner BG; McCrea EL; Margolese RG
    Anticancer Res; 1988; 8(4):653-8. PubMed ID: 3263077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
    Burns GF; Triglia T; Werkmeister JA
    J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential substages of natural killer cell-derived cytolytic factor (NKCF)-mediated cytolysis as defined by glutaraldehyde modulation of the target cell.
    Deem RL; Targan SR
    J Immunol; 1984 Oct; 133(4):1836-40. PubMed ID: 6432901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of differentiation inducers on the sensitivity of two myeloid cell lines to natural killer (NK) cell-mediated lysis.
    Golden M; Dempsey RA; Mier JW; Parkinson DR
    Int J Immunopharmacol; 1983; 5(5):411-9. PubMed ID: 6197382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility to natural killer cell-mediated cytolysis is independent of the level of target cell class I HLA expression.
    Leiden JM; Karpinski BA; Gottschalk L; Kornbluth J
    J Immunol; 1989 Mar; 142(6):2140-7. PubMed ID: 2493507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compared mechanisms of tumor cytolysis by human natural killer cells and activated polymorphonuclear leukocytes.
    Abrams SI; Brahmi Z
    J Immunol; 1984 Jun; 132(6):3192-6. PubMed ID: 6327820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C; Lopez C
    J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the mechanism of the human natural killer cell lethal hit: analysis of the mechanism of protease inhibition of the lethal hit.
    Hiserodt JC; Britvan L; Targan SR
    J Immunol; 1983 Dec; 131(6):2705-9. PubMed ID: 6358352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.